Literature DB >> 21695548

Can we prevent or treat renal dysfunction in chronic heart failure?

Daniela Dobre1, Patrick Rossignol, Marco Metra, Faiez Zannad.   

Abstract

We aimed to summarize the predictors of renal dysfunction and present strategies to prevent and/or treat renal dysfunction in Chronic Heart Failure (CHF). Several factors may predict renal dysfunction in CHF, including older age, comorbidities (anemia, hypertension, diabetes), severity of underlying heart disease (systolic and diastolic dysfunction, central venous pressure) as well as certain therapies in specific circumstances (diuretics, nonsteroid acute inflammatory drugs, and renine-angiotensin-aldosterone (RAAS) inhibitors). Thus, prevention of renal dysfunction is possible in CHF by treating comorbidities and underlying heart disease as well as by monitoring therapies with potential toxic renal effect. At present, there is no specific treatment for renal dysfunction, but several new entities are under investigation. In conclusion, prevention of renal dysfunction is possible in CHF, but treatment is still under investigation. New studies are necessary to establish whether a specific algorithm may be used to prevent renal dysfunction in CHF patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21695548     DOI: 10.1007/s10741-011-9264-0

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  55 in total

1.  Why is chronic kidney disease the "spoiler" for cardiovascular outcomes?

Authors:  Peter A McCullough
Journal:  J Am Coll Cardiol       Date:  2003-03-05       Impact factor: 24.094

2.  Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function.

Authors:  C D Frances; H Noguchi; B M Massie; W S Browner; M McClellan
Journal:  Arch Intern Med       Date:  2000-09-25

3.  Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial.

Authors:  A S Al-Khadra; D N Salem; W M Rand; J E Udelson; J J Smith; M A Konstam
Journal:  J Am Coll Cardiol       Date:  1998-02       Impact factor: 24.094

Review 4.  Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure.

Authors:  M Packer
Journal:  Circulation       Date:  1988-06       Impact factor: 29.690

5.  Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.

Authors:  Kevin Damman; Dirk J Van Veldhuisen; Gerjan Navis; Vishal S Vaidya; Tom D J Smilde; B Daan Westenbrink; Joseph V Bonventre; Adriaan A Voors; Hans L Hillege
Journal:  Heart       Date:  2010-08       Impact factor: 5.994

6.  Acute administration of diclofenac, but possibly not long term low dose aspirin, causes detrimental renal effects in heart failure patients treated with ACE-inhibitors.

Authors:  Tord Juhlin; Sven Björkman; Bodil Gunnarsson; Asa Fyge; Bodil Roth; Peter Höglund
Journal:  Eur J Heart Fail       Date:  2004-12       Impact factor: 15.534

7.  Relation of blood urea nitrogen to long-term mortality in patients with heart failure.

Authors:  Clay A Cauthen; Michael J Lipinski; Antonio Abbate; Darryn Appleton; Annunziata Nusca; Amit Varma; Evelyne Goudreau; Michael J Cowley; George W Vetrovec
Journal:  Am J Cardiol       Date:  2008-04-09       Impact factor: 2.778

8.  Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.

Authors:  Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; John J V McMurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick de Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690

9.  Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction.

Authors:  Kevin Damman; Gerjan Navis; Tom D J Smilde; Adriaan A Voors; Wim van der Bij; Dirk J van Veldhuisen; Hans L Hillege
Journal:  Eur J Heart Fail       Date:  2007-06-22       Impact factor: 15.534

Review 10.  beta-Adrenoceptor antagonists in elderly patients with heart failure: a critical review of their efficacy and tolerability.

Authors:  Daniela Dobre; Flora M Haaijer-Ruskamp; Adriaan A Voors; Dirk J van Veldhuisen
Journal:  Drugs Aging       Date:  2007       Impact factor: 4.271

View more
  1 in total

Review 1.  Clinical use of novel biomarkers in heart failure: towards personalized medicine.

Authors:  Daniela Schmitter; Gadi Cotter; Adriaan A Voors
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.